Cipla Q1 results: Consolidated PAT rises 24% YoY, beats estimate; sales jump 27%

MUMBAI: today reported a 24 per cent year-on-year rise in its consolidated net profit to Rs. 715 crore for the quarter ended June, which was higher than Streets expectations.
The pharmaceutical major reported a 27 per cent rise in income from operations…

Click here to view the original article.